Testosterone Replacement Therapy and the Risk of Hypoglycemia
Joint Authors
Yamaguchi, Analía Verónica
Peuchot, Verónica Andrea
Knoblovits, Pablo
Costanzo, Pablo R.
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-11-17
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
We report the case of a 45-year-old man with a history of Klinefelter syndrome undergoing testosterone replacement therapy, and with type 2 diabetes treated with metformin with poor metabolic control.
When vildagliptin was added to his treatment, he presented hypoglycemia after the testosterone injection.
We highlight this not widely reported drug interaction between hypoglycemic agents and testosterone.
American Psychological Association (APA)
Yamaguchi, Analía Verónica& Costanzo, Pablo R.& Peuchot, Verónica Andrea& Knoblovits, Pablo. 2019. Testosterone Replacement Therapy and the Risk of Hypoglycemia. Case Reports in Endocrinology،Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1135867
Modern Language Association (MLA)
Yamaguchi, Analía Verónica…[et al.]. Testosterone Replacement Therapy and the Risk of Hypoglycemia. Case Reports in Endocrinology No. 2019 (2019), pp.1-5.
https://search.emarefa.net/detail/BIM-1135867
American Medical Association (AMA)
Yamaguchi, Analía Verónica& Costanzo, Pablo R.& Peuchot, Verónica Andrea& Knoblovits, Pablo. Testosterone Replacement Therapy and the Risk of Hypoglycemia. Case Reports in Endocrinology. 2019. Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1135867
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1135867
